Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antriabio Inc (OTCQB:ANTB)

1.14
Delayed Data
As of Apr 25
 +0.09 / +8.57%
Today’s Change
0.63
Today|||52-Week Range
2.00
+14.00%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Internet Software/Services
MARKET CAP
$46.7M

Company Description

AntriaBio, Inc. is biopharmaceutical company, which engages in the development of novel and sustained release injectable therapies. Its products includes antriabio 101 for type 1 and type 2 diabetes, and antriabio 301, which an insulin combination for type 2 diabetes only. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Louisville, CO.

Contact Information

AntriaBio, Inc.
1450 Infinite Drive
Louisville Colorado 80027
P:(303) 222-2128
Investor Relations:

Employees

Shareholders

Individual stakeholders26.77%
Mutual fund holders--
Other institutional--

Top Executives

Nevan Charles ElamChairman & Chief Executive Officer
Michael DeperroVice President-Operations
Sankaram MantripragadaChief Scientific Officer
Ho Young HuhDirector & Head-Business Development
Noopur Batsha LiffickVice President-Corporate Development